HIV Antiretroviral Therapy Costs in the United States, 2012-2018.
Where this comes from
- Record sourced from PubMed, PMID 32011622.
- Also identified by DOI 10.1001/jamainternmed.2019.7108 and PMC identifier 7042880.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
This study characterizes the costs of recommended initial HIV antiretroviral therapy regimens in the United States from 2012 to 2018 and the magnitude of cost changes over time.
Medical subject headings
- Anti-Retroviral Agents
- Antiretroviral Therapy, Highly Active
- HIV Infections